YES Fundamental Analysis - CHAR TECHNOLOGIES LTD

Fundamental Rating

YES gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 24 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of YES have multiple concerns. While showing a medium growth rate, YES is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

YES had negative earnings in the past year.

YES had a negative operating cash flow in the past year.

In the past 5 years YES always reported negative net income.

YES had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -46.10%, YES is not doing good in the industry: 83.33% of the companies in the same industry are doing better.

YES has a worse Return On Equity (-852.16%) than 70.83% of its industry peers.

		Industry Rank	Sector Rank
ROA	-46.1%
ROE	-852.16%
ROIC	N/A

ROA(3y)-54.36%

ROA(5y)-43.07%

ROE(3y)-621.21%

ROE(5y)-395.25%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 25.54%, YES perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

YES's Gross Margin has declined in the last couple of years.

YES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	25.54%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-27.06%

GM growth 5Y-17.93%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

YES does not have a ROIC to compare to the WACC, probably because it is not profitable.

YES has more shares outstanding than it did 1 year ago.

YES has more shares outstanding than it did 5 years ago.

The debt/assets ratio for YES is higher compared to a year ago.

2.2 Solvency

YES has an Altman-Z score of -2.53. This is a bad value and indicates that YES is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -2.53, YES is doing worse than 83.33% of the companies in the same industry.

YES has a Debt/Equity ratio of 5.58. This is a high value indicating a heavy dependency on external financing.

Looking at the Debt to Equity ratio, with a value of 5.58, YES is doing worse than 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	5.58
Debt/FCF	N/A
Altman-Z	-2.53

ROIC/WACCN/A

WACC7.4%

2.3 Liquidity

YES has a Current Ratio of 0.62. This is a bad value and indicates that YES is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.62, YES is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

A Quick Ratio of 0.62 indicates that YES may have some problems paying its short term obligations.

YES's Quick ratio of 0.62 is on the low side compared to the rest of the industry. YES is outperformed by 70.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.62
Quick Ratio	0.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.12% over the past year.

The Revenue for YES has decreased by -27.34% in the past year. This is quite bad

YES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.27% yearly.

EPS 1Y (TTM)36.12%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-34.62%

Revenue 1Y (TTM)-27.34%

Revenue growth 3Y31.9%

Revenue growth 5Y14.27%

Sales Q2Q%-62.38%

3.2 Future

The Earnings Per Share is expected to grow by 22.92% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 100.89% on average over the next years. This is a very strong growth

EPS Next Y0%

EPS Next 2Y25.36%

EPS Next 3Y22.92%

EPS Next 5YN/A

Revenue Next Year-34.03%

Revenue Next 2Y128.52%

Revenue Next 3Y100.89%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

YES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year YES is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as YES's earnings are expected to grow with 22.92% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y25.36%

EPS Next 3Y22.92%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

YES does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHAR TECHNOLOGIES LTD

TSX-V:YES (12/29/2025, 7:00:00 PM)

0.315

+0.03 (+12.5%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)09-01 2025-09-01

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners8.62%

Ins Owner ChangeN/A

Market Cap40.63M

Revenue(TTM)2.27M

Net Income(TTM)-6.81M

Analysts86.67

Price Target0.56 (77.78%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	17.87
P/FCF	N/A
P/OCF	N/A
P/B	50.83
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.06

EYN/A

EPS(NY)-0.03

Fwd EYN/A

FCF(TTM)-0.06

FCFYN/A

OCF(TTM)-0.05

OCFYN/A

SpS0.02

BVpS0.01

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-46.1%
ROE	-852.16%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	25.54%
FCFM	N/A

ROA(3y)-54.36%

ROA(5y)-43.07%

ROE(3y)-621.21%

ROE(5y)-395.25%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-27.06%

GM growth 5Y-17.93%

F-Score4

Asset Turnover0.15

Health

		Industry Rank	Sector Rank
Debt/Equity	5.58
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	99.89%
Cap/Sales	56.76%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.62
Quick Ratio	0.62
Altman-Z	-2.53

F-Score4

WACC7.4%

ROIC/WACCN/A

Cap/Depr(3y)236.11%

Cap/Depr(5y)179.21%

Cap/Sales(3y)176.7%

Cap/Sales(5y)128.78%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)36.12%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-34.62%

EPS Next Y0%

EPS Next 2Y25.36%

EPS Next 3Y22.92%

EPS Next 5YN/A

Revenue 1Y (TTM)-27.34%

Revenue growth 3Y31.9%

Revenue growth 5Y14.27%

Sales Q2Q%-62.38%

Revenue Next Year-34.03%

Revenue Next 2Y128.52%

Revenue Next 3Y100.89%

Revenue Next 5YN/A

EBIT growth 1Y31.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year17.9%

EBIT Next 3Y35.37%

EBIT Next 5YN/A

FCF growth 1Y-253.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-393.9%

OCF growth 3YN/A

OCF growth 5YN/A

CHAR TECHNOLOGIES LTD / YES.CA FAQ

What is the ChartMill fundamental rating of CHAR TECHNOLOGIES LTD (YES.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to YES.CA.

What is the valuation status for YES stock?

ChartMill assigns a valuation rating of 1 / 10 to CHAR TECHNOLOGIES LTD (YES.CA). This can be considered as Overvalued.

How profitable is CHAR TECHNOLOGIES LTD (YES.CA) stock?

CHAR TECHNOLOGIES LTD (YES.CA) has a profitability rating of 0 / 10.

Can you provide the expected EPS growth for YES stock?

The Earnings per Share (EPS) of CHAR TECHNOLOGIES LTD (YES.CA) is expected to decline by 0% in the next year.

CHAR TECHNOLOGIES LTD (YES.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CHAR TECHNOLOGIES LTD / YES.CA FAQ

What is the ChartMill fundamental rating of CHAR TECHNOLOGIES LTD (YES.CA) stock?

What is the valuation status for YES stock?

How profitable is CHAR TECHNOLOGIES LTD (YES.CA) stock?

Can you provide the expected EPS growth for YES stock?